» Articles » PMID: 31371966

Factors Related to Lithium Blood Concentrations in Chinese Han Patients with Bipolar Disorder

Overview
Publisher Dove Medical Press
Specialty Psychiatry
Date 2019 Aug 3
PMID 31371966
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The goal of this study was to identify the physiological factors related to the blood concentration of lithium in Chinese Han patients with bipolar disorder (BD). A total of 186 Chinese Han patients with BD were assessed. Patients were recruited from the Anhui Mental Health Center. The concentrations of serum lithium were measured by a Dimension RxL Max biochemistry analyzer. Physiological factors, including body weight, body mass index (BMI), and routine laboratory parameters, were collected. Relationships between the serum lithium concentration and relevant clinical data were analyzed by Pearson correlation tests, and the independent relationships were determined by multivariate linear regression analysis. Pearson correlation analysis showed that serum lithium concentrations were positively correlated with creatinine concentrations (r=0.147, =0.046), Mg concentrations (r=0.151, =0.04), and the percentage of neutrophils (r=0.178, =0.015) and negatively correlated with high-density lipoprotein (HDL) concentrations (r=-0.142, =0.05), apolipoprotein A1 concentrations (r=-0.169, =0.02), and Na concentrations (r=-0.148, =0.046) in 186 patients with BD. Furthermore, multivariate linear regression analysis showed that serum lithium concentrations were negatively associated with Na concentrations and positively associated with the percentage of neutrophils. These results suggest that physiological factors, including creatinine, HDL, apolipoprotein A1, Na, and Mg concentrations and percentage of neutrophils, might be related to serum lithium concentrations and provide a basis for parameter selection of lithium population pharmacokinetics in Chinese Han patients with BD.

Citing Articles

External Evaluation of Population Pharmacokinetics Models of Lithium in the Bipolar Population.

Aurelie L, Andrea B, Gauvind K, Olivier B, Raoul B, Dayan F Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004492 PMC: 10674621. DOI: 10.3390/ph16111627.


Individualization of lithium therapy based on the monitoring of its level in saliva.

Kuczynska J, Zakrzewska-Sito A Postep Psychiatr Neurol. 2023; 30(4):251-257.

PMID: 37082561 PMC: 9881638. DOI: 10.5114/ppn.2021.111938.


Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology.

Ziani P, Feiten J, Goularte J, Colombo R, Antqueviezc B, Gea L Clin Psychopharmacol Neurosci. 2022; 20(2):211-227.

PMID: 35466093 PMC: 9048014. DOI: 10.9758/cpn.2022.20.2.211.


Saliva testing as a means to monitor therapeutic lithium levels in patients with psychiatric disorders: Identification of clinical and environmental covariates, and their incorporation into a prediction model.

Parkin G, McCarthy M, Thein S, Piccerillo H, Warikoo N, Granger D Bipolar Disord. 2021; 23(7):679-688.

PMID: 34536974 PMC: 9291088. DOI: 10.1111/bdi.13128.


Population Pharmacokinetics of Lithium in Young Pediatric Patients With Intellectual Disability.

Yuan J, Zhang B, Xu Y, Zhang X, Song J, Zhou W Front Pharmacol. 2021; 12:650298.

PMID: 33935755 PMC: 8082156. DOI: 10.3389/fphar.2021.650298.

References
1.
Phiel C, Klein P . Molecular targets of lithium action. Annu Rev Pharmacol Toxicol. 2001; 41:789-813. DOI: 10.1146/annurev.pharmtox.41.1.789. View

2.
Sporn A, Gogtay N, Ortiz-Aguayo R, Alfaro C, Tossell J, Lenane M . Clozapine-induced neutropenia in children: management with lithium carbonate. J Child Adolesc Psychopharmacol. 2003; 13(3):401-4. DOI: 10.1089/104454603322572697. View

3.
Dean B, Digney A, Sundram S, Thomas E, Scarr E . Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder. Psychiatry Res. 2007; 158(1):75-8. DOI: 10.1016/j.psychres.2007.05.008. View

4.
Shen H, Li J, Lo Y . Lithium intoxication-induced acute parkinsonism complicated with hyperparathyroidism and nephrogenic diabetes insipidus: report of a case. Acta Neurol Taiwan. 2008; 16(4):231-3. View

5.
Ghaznavi S, Nakic M, Rao P, Hu J, Brewer J, Hannestad J . Rechallenging with clozapine following neutropenia: treatment options for refractory schizophrenia. Am J Psychiatry. 2008; 165(7):813-8. DOI: 10.1176/appi.ajp.2008.07111823. View